Urological cancer, Malmö
521 – 530 of 553
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
- Contribution to journal › Article
-
Mark
Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.
- Contribution to journal › Article
-
Mark
Systemic interleukin-6 response to colorectal surgery originates from the bowel.
- Contribution to journal › Article
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
- Contribution to journal › Article
- 2000
-
Mark
Increased presence of cells containing transforming growth factor alpha (TGF-alpha) in ulcerative colitis, both during active inflammation and in remission
- Contribution to journal › Article
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
- Contribution to journal › Article
-
Mark
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
- Contribution to journal › Article
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
- Contribution to journal › Article
-
Mark
Expression and characterization of trypsinogen produced in the human male genital tract
- Contribution to journal › Article
- 1999
-
Mark
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer
- Contribution to journal › Article
